Atara Biotherapeutics Analyst Ratings
BenzingaApr 1 22:53
Stifel Adjusts Atara Biotherapeutics Price Target to $2.30 From $4.80, Maintains Hold Rating
MT NewswiresApr 1 21:27
Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA) and Embecta Corporation (EMBC)
TipRanksApr 1 19:30
Analysts Offer Insights on Healthcare Companies: Affimed (AFMD) and Atara Biotherapeutics (ATRA)
TipRanksApr 1 10:20
Atara Biotherapeutics (ATRA) Gets a Buy From TD Cowen
TipRanksMar 29 04:06
Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA), Moderna (MRNA) and Madrigal Pharmaceuticals (MDGL)
TipRanksMar 1 21:00
Goldman Sachs Maintains Sell on Atara Biotherapeutics, Lowers Price Target to $0.5
BenzingaNov 10, 2023 23:54
Atara Biotherapeutics Analyst Ratings
BenzingaNov 10, 2023 23:53
Goldman Sachs Sticks to Its Sell Rating for Atara Biotherapeutics (ATRA)
TipRanksNov 9, 2023 21:29
Atara Biotherapeutics Analyst Ratings
BenzingaNov 9, 2023 20:11
Mizuho Securities Downgrades Atara Biotherapeutics to Neutral From Buy, Slashes Price Target to $1 From $31
MT NewswiresNov 9, 2023 19:57
Analysts Offer Insights on Healthcare Companies: Amphastar Pharmaceuticals (AMPH), Atara Biotherapeutics (ATRA) and Tempest Therapeutics (TPST)
TipRanksNov 9, 2023 19:54
H.C. Wainwright Downgrades Atara Biotherapeutics (ATRA) to a Hold
TipRanksNov 9, 2023 19:53
Analysts Have Conflicting Sentiments on These Healthcare Companies: Vir Biotechnology (VIR) and Atara Biotherapeutics (ATRA)
TipRanksNov 6, 2023 18:11
HC Wainwright & Co. Reiterates Buy on Atara Biotherapeutics, Maintains $28 Price Target
BenzingaSep 26, 2023 18:35
Atara Biotherapeutics Analyst Ratings
BenzingaSep 26, 2023 18:34
Analysts Offer Insights on Healthcare Companies: Aptose Biosciences (APTO), Harmony Biosciences Holdings (HRMY) and Atara Biotherapeutics (ATRA)
TipRanksSep 21, 2023 19:32
Citigroup Maintains Sell on Atara Biotherapeutics, Lowers Price Target to $1.4
BenzingaAug 21, 2023 19:43
Atara Biotherapeutics Analyst Ratings
BenzingaAug 21, 2023 19:42
EF Hutton Reiterates Buy on Atara Biotherapeutics, Maintains $25 Price Target
BenzingaAug 9, 2023 19:26
No Data
No Data